Mehrad Adibi

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

20h-index1.4kcitations79works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(30), Renal cell carcinoma treatment(29), Urinary and Genital Oncology Studies(18), Renal and related cancers(14), Urological Disorders and Treatments(10)

Publications79 total

Genotype-Phenotype Characterization of Lynch Syndrome–associated Upper Tract Urothelial Carcinoma
European Urology Oncology·2025· 1 cited
The uTRACT registry: A single-arm, multicenter, prospective, and retrospective registry study to evaluate the real-world use of UGN-101 in participants with upper tract urothelial carcinoma (UTUC) in the United States.
Journal of Clinical Oncology·2025· 1 cited
IP12-21 VALIDATION OF AUA UPPER TRACT UROTHELIAL CARCINOMA PRESURGICAL CLINICAL RISK STRATIFICATION FOR PREDICTING INVASIVE DISEASE
The Journal of Urology·2025
IP12-27 OUTCOMES OF PRIMARY CHEMOTHERAPY FOLLOWED BY NEPHROURETERECTOMY AND RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH CLINICALLY NODE POSITIVE UTUC
The Journal of Urology·2025
The Upper TRACT Endometry Score: Development and Internal Validation of an Objective Measure of Variables That Affect Endoscopic Procedures for Upper Tract Urothelial Carcinoma
The Journal of Urology·2025· 1 cited
OUTCOMES OF PRIMARY CHEMOTHERAPY FOLLOWED BY NEPHROURETERECTOMY AND RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH CLINICALLY NODE POSITIVE UTUC
Urologic Oncology Seminars and Original Investigations·2025
DOES INCLUSION OF GRADE GROUP 1 CORE VOLUME AT TIME OF FUSION BIOPSY IMPACT RATE OF ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY?
Urologic Oncology Seminars and Original Investigations·2025Open Access
Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience
International Journal of Radiation Oncology*Biology*Physics·2024
Prognostic factors of relapse in surgically resected small cell neuroendocrine carcinomas of the urothelial tract (SCNEC-URO).
Journal of Clinical Oncology·2024· 2 cited
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma
The Journal of Urology·2024· 8 citedOpen Access
Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer
Urologic Oncology Seminars and Original Investigations·2024· 6 cited
Clinical outcomes of frontline GemFLP in advanced urachal and non-urachal adenocarcinomas of the urinary tract: The MD Anderson Cancer Center (MDACC) experience.
Journal of Clinical Oncology·2024· 7 cited
The association of body mass index with tumor aggression among men undergoing radical prostatectomy
Urologic Oncology Seminars and Original Investigations·2024· 1 cited
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma <i>via</i> percutaneous nephrostomy tube: a <scp>multi‐institutional</scp> retrospective cohort study
British Journal of Urology·2022· 6 citedOpen Access
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma
Urologic Oncology Seminars and Original Investigations·2022· 3 cited
PD15-04 GENOTYPE-PHENOTYPE CHARACTERIZATION OF LYNCH SYNDROME ASSOCIATED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
The Journal of Urology·2022
LBA01-10 INTERIM RESULTS FROM A PHASE 1B CLINICAL TRIAL EVALUATING TOLERABILITY AND ACTIVITY OF FGFR INHIBITION IN LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
The Journal of Urology·2022
MP47-20 UNIVERSAL GERMLINE GENETIC TESTING OF PATIENTS WITH NEWLY DIAGNOSED UPPER TRACT UROTHELIAL CARCINOMA: AN INTERIM ANALYSIS
The Journal of Urology·2022· 1 cited
MP16-14 APIXABAN VERSUS ENOXAPARIN FOR POST-SURGICAL EXTENDED DURATION VTE PROPHYLAXIS: A PROSPECTIVE QUALITY IMPROVEMENT STUDY
The Journal of Urology·2022
PD58-06 ANTEGRADE ADMINISTRATION OF REVERSE THERMAL MITOMYCIN GEL FOR PRIMARY CHEMOABLATION OF UPPER TRACT UROTHELIAL CARCINOMA VIA PERCUTANEOUS NEPHROSTOMY TUBE: A MULTI-INSTITUTIONAL REAL-WORLD EXPERIENCE
The Journal of Urology·2022
page 1 of 4Next →

Frequent Co-authors

Surena F. Matin(18), Christopher G. Wood(15), José A. Karam(15), Arun Z. Thomas(13), Leonardo D. Borregales(11), Pheroze Tamboli(8), Ganesh V. Raj(7), Eric Jonasch(7), Nizar M. Tannir(7), Paul G. Corn(7), Curtis A. Pettaway(7), Jeffrey A. Cadeddu(6), Arthur I. Sagalowsky(6), Vitaly Margulis(6), Amishi Y. Shah(6), Matthew T. Campbell(6), Ashish M. Kamat(5), Jianjun Gao(5), Arlene O. Siefker‐Radtke(5), Charles C. Guo(5)